Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area
Kostandinos Sideras, Steven Bots, Katharina Biermann, et al.
British Journal of Cancer (2015) Vol. 112, Iss. 12, pp. 1911-1920
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
Guoying Zhou, Dave Sprengers, Patrick P.C. Boor, et al.
Gastroenterology (2017) Vol. 153, Iss. 4, pp. 1107-1119.e10
Closed Access | Times Cited: 356
Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma
Katharina Leuchte, E Staib, Martin Thelen, et al.
Cancer Immunology Immunotherapy (2020) Vol. 70, Iss. 4, pp. 893-907
Open Access | Times Cited: 102
Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma
Yang Cheng, Bavani Gunasegaran, Harsimran Singh, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1825-1840.e7
Open Access | Times Cited: 97
Immunotherapy in hepatocellular carcinoma
Luigi Buonaguro, Angela Mauriello, Beatrice Cavalluzzo, et al.
Annals of Hepatology (2019) Vol. 18, Iss. 2, pp. 291-297
Open Access | Times Cited: 77
TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma
Zhouhong Ge, Guoying Zhou, Lucia Campos Carrascosa, et al.
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 12, Iss. 2, pp. 443-464
Open Access | Times Cited: 62
Immunotherapy for hepatocellular carcinoma
Alexa Childs, Gloryanne Aidoo-Micah, Mala K. Maini, et al.
JHEP Reports (2024) Vol. 6, Iss. 10, pp. 101130-101130
Closed Access | Times Cited: 13
A comprehensive review and in silico analysis of the role of survivin (BIRC5) in hepatocellular carcinoma hallmarks: A step toward precision
Nesrine A Mohamed, Rania Hassan Mohamed, John F. Kennedy, et al.
International Journal of Biological Macromolecules (2025) Vol. 311, pp. 143616-143616
Closed Access | Times Cited: 1
GITR ligation enhances functionality of tumor‐infiltrating T cells in hepatocellular carcinoma
Adriaan A. van Beek, Guoying Zhou, Michail Doukas, et al.
International Journal of Cancer (2019) Vol. 145, Iss. 4, pp. 1111-1124
Open Access | Times Cited: 55
Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials
Philippe Rochigneux, Brice Chanez, Bernadette de Rauglaudre, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 271-271
Open Access | Times Cited: 54
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors
Timothy T. Spear, Glenda G. Callender, J. Roszkowski, et al.
Cancer Immunology Immunotherapy (2016) Vol. 65, Iss. 3, pp. 293-304
Open Access | Times Cited: 48
CD8+ T Cell Responses during HCV Infection and HCC
Maike Hofmann, Catrin Tauber, Nina Hensel, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 5, pp. 991-991
Open Access | Times Cited: 35
The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
Peter G. Hendrickson, Michael Olson, Tim Luetkens, et al.
OncoImmunology (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 36
SALL Proteins; Common and Antagonistic Roles in Cancer
Claudia Álvarez, Aracelly Quiroz, Diego Benítez-Riquelme, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6292-6292
Open Access | Times Cited: 26
Novel Cellular Therapies for Hepatocellular Carcinoma
Harriet Roddy, Tim Meyer, Claire Roddie
Cancers (2022) Vol. 14, Iss. 3, pp. 504-504
Open Access | Times Cited: 18
Current Landscape of Adoptive Cell Therapy and Challenge to Develop “Off‐The‐Shelf” Therapy for Hepatocellular Carcinoma
Seung Kak Shin, Y. Mishima, Yoonseok Lee, et al.
Journal of Gastroenterology and Hepatology (2025)
Open Access
Bioinformatics-driven identification of key non-invasive prognostic biomarkers in hepatocellular carcinoma
Muhammad‐Redha Abdullah‐Zawawi, Muhammad Irfan Abdul Jalal, Shing Cheng Tan, et al.
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access
Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma
Jun Liu, Kevin Park, Ziyang Shen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Treatment Options for Hepatocellular Carcinoma Using Immunotherapy: Present and Future
Hongbin Wei, Chunlu Dong, Xun Li
Journal of Clinical and Translational Hepatology (2024) Vol. 12, Iss. 4, pp. 389-405
Open Access | Times Cited: 3
Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer
Chel Hun Choi, Joon‐Yong Chung, Eun Joo Chung, et al.
BMC Cancer (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 24
Inefficient induction of circulating TAA-specific CD8+ T-cell responses in hepatocellular carcinoma
Catrin Tauber, Michael Schultheiß, Raffaele De Luca, et al.
Oncotarget (2019) Vol. 10, Iss. 50, pp. 5194-5206
Open Access | Times Cited: 23
Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers
Guoying Zhou, Patrick P.C. Boor, Marco J. Bruno, et al.
British Journal of Cancer (2021) Vol. 126, Iss. 1, pp. 10-23
Open Access | Times Cited: 20
Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma
Zhouhong Ge, Jean Helmijr, Maurice P.H.M. Jansen, et al.
Translational Oncology (2021) Vol. 14, Iss. 7, pp. 101073-101073
Open Access | Times Cited: 17
Immunotoxins Immunotherapy against Hepatocellular Carcinoma: A Promising Prospect
Mohammad Heiat, Hamid Hashemi Yeganeh, Seyed Moayed Alavian, et al.
Toxins (2021) Vol. 13, Iss. 10, pp. 719-719
Open Access | Times Cited: 17
Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma
Kumar Jayant, Nagy Habib, Kai‐Wen Huang, et al.
Diagnostics (2020) Vol. 10, Iss. 5, pp. 338-338
Open Access | Times Cited: 17
Innate immune response restarts adaptive immune response in tumors
Wen-shan Li, Qingqing Zhang, Qiao Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top